Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|February 23, 2010
Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370Zvi Hayouka, Aviad Levin, Michal Maes, et al.Disease Models & Mechanisms|July 27, 2013
Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrusEran Hadas, Wei Chao, Hongxia He, et al.Respiratory Research|February 6, 2026
CXCL11 levels regulate lung Treg responses to deter the onset of HIV-related COPDAbdoulaye J Dabo, Patrick Geraghty, Oleg Evgrafov, et al.Journal of Neuropathology and Experimental Neurology|December 17, 2013
Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responsesHongxia He, Leroy R Sharer, Wei Chao, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|October 12, 2011
Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIVJennifer L Kelschenbach, Manisha Saini, Eran Hadas, et al.Journal of Leukocyte Biology|June 25, 2020
Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairmentMatias Jaureguiberry-Bravo, Jennifer Kelschenbach, Aniella Murphy, et al.AIDS (London, England)|April 5, 2019
Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected miceBoe-Hyun Kim, Jennifer Kelschenbach, Alejandra Borjabad, et al.Plos Pathogens|June 8, 2018
EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairmentChao-Jiang Gu, Alejandra Borjabad, Eran Hadas, et al.Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|June 19, 2019
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive DisordersMichael T Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.Journal of Medicinal Chemistry|August 1, 2017
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive DisordersMichael T Nedelcovych, Lukáš Tenora, Boe-Hyun Kim, et al.Pageof 3